Neurovascular Devices Market Size, Share & Trends Analysis Report By Device, By Therapeutic Applications, By End Use, By Region, And Segment Forecasts, 2026 - 2033

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Device
  • 1.2.2. Therapeutic Applications
  • 1.2.3. End Use
  • 1.2.4. Regional Scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Neurovascular Devices Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Prevalence of Neurovascular Diseases
    • 3.2.1.2. Technological Advancements In Neurovascular Devices
    • 3.2.1.3. Rising Number of Awareness Initiatives
    • 3.2.1.4. Increasing Demand For Minimally Invasive Procedures
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Product Recalls
    • 3.2.2.2. High Treatment Cost Associated With Neurovascular Disorders
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Growing Number of Clinical Trials
    • 3.2.3.2. Launches Of Novel Products
    • 3.2.3.3. Increasing Research & Development Activities
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Shortage of Skilled Professionals
    • 3.2.4.2. Potential Complications & Risks associated with Neurovascular Devices
• 3.3. Neurovascular Devices Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Neurovascular Devices Market: Segment Analysis, By Device, 2021 - 2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Segment Dashboard
• 4.3. Device Market Share Analysis, 2025 & 2033
• 4.4. Global Neurovascular Devices Market, by Device, 2021 to 2033
• 4.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033
  • 4.5.1. Cerebral Embolization and Aneurysm coiling devices
    • 4.5.1.1. Cerebral embolization and aneurysm coiling devices market, 2021 - 2033 (USD Million)
    • 4.5.1.2. Embolic coils
      • 4.5.1.2.1. Embolic coils market, 2021 - 2033 (USD Million)
    • 4.5.1.3. Flow diverters
      • 4.5.1.3.1. Flow diverters market, 2021 - 2033 (USD Million)
    • 4.5.1.4. Liquid embolic agents
      • 4.5.1.4.1. Liquid embolic agents market, 2021 - 2033 (USD Million)
  • 4.5.2. Cerebral angioplasty and stenting systems
    • 4.5.2.1. Cerebral angioplasty and stenting systems market, 2021 - 2033 (USD Million)
    • 4.5.2.2. Carotid Artery Stents
      • 4.5.2.2.1. Carotid artery stents market, 2021 - 2033 (USD Million)
    • 4.5.2.3. Embolic Protection Devices
      • 4.5.2.3.1. Embolic protection systems devices market, 2021 - 2033 (USD Million)
  • 4.5.3. Neurothrombectomy devices
    • 4.5.3.1. Neurothrombectomy devices market, 2021 - 2033 (USD Million)
    • 4.5.3.2. Clot Retrieval Devices
      • 4.5.3.2.1. Clot retrieval devices market, 2021 - 2033 (USD Million)
    • 4.5.3.3. Suction Devices
      • 4.5.3.3.1. Suction devices market, 2021 - 2033 (USD Million)
    • 4.5.3.4. Vascular Snares
      • 4.5.3.4.1. Vascular snares market, 2021 - 2033 (USD Million)
  • 4.5.4. Support devices
    • 4.5.4.1. Support devices market, 2021 - 2033 (USD Million)
    • 4.5.4.2. By Product
      • 4.5.4.2.1. Micro Catheters
        • 4.5.4.2.1.1. Micro catheters market, 2021 - 2033 (USD Million)
      • 4.5.4.2.2. Micro Guidewires
        • 4.5.4.2.2.1. Micro guidewires market, 2021 - 2033 (USD Million)
    • 4.5.4.3. By Size
      • 4.5.4.3.1. 0.027"
        • 4.5.4.3.1.1. 0.027" market, 2021 - 2033 (USD Million)
      • 4.5.4.3.2. 0.021"
        • 4.5.4.3.2.1. 0.021" market, 2021 - 2033 (USD Million)
      • 4.5.4.3.3. 0.071"
        • 4.5.4.3.3.1. 0.071" market, 2021 - 2033 (USD Million)
      • 4.5.4.3.4. 0.017"
        • 4.5.4.3.4.1. 0.017" market, 2021 - 2033 (USD Million)
      • 4.5.4.3.5. 0.019"
        • 4.5.4.3.5.1. 0.019" market, 2021 - 2033 (USD Million)
      • 4.5.4.3.6. 0.013"
        • 4.5.4.3.6.1. 0.013" market, 2021 - 2033 (USD Million)
      • 4.5.4.3.7. 0.058"
        • 4.5.4.3.7.1. 0.058" market, 2021 - 2033 (USD Million)
      • 4.5.4.3.8. 0.068"
        • 4.5.4.3.8.1. 0.068" market, 2021 - 2033 (USD Million)
      • 4.5.4.3.9. Others
        • 4.5.4.3.9.1. Others market, 2021 - 2033 (USD Million)
  • 4.5.5. Trans Radial Access Devices
    • 4.5.5.1. Trans radial access devices market, 2021 - 2033 (USD Million)

Chapter 5. Neurovascular Devices Market: Segment Analysis, By Therapeutic Applications, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. Segment Dashboard
• 5.3. Therapeutic Applications Market Share Analysis, 2025 & 2033
• 5.4. Global Neurovascular Devices Market, by Therapeutic Applications, 2021 to 2033
• 5.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033
  • 5.5.1. Stroke
    • 5.5.1.1. Stroke market, 2021 - 2033 (USD Million)
  • 5.5.2. Cerebral artery stenosis
    • 5.5.2.1. Cerebral artery stenosis market, 2021 - 2033 (USD Million)
  • 5.5.3. Cerebral aneurysm
    • 5.5.3.1. Cerebral aneurysm market, 2021 - 2033 (USD Million)
    • 5.5.3.2. Aneurysmal Subarachnoid Hemorrhage
      • 5.5.3.2.1. Aneurysmal subarachnoid hemorrhage market, 2021 - 2033 (USD Million)
    • 5.5.3.3. Others
      • 5.5.3.3.1. Others market, 2021 - 2033 (USD Million)
  • 5.5.4. Others
    • 5.5.4.1. Others market, 2021 - 2033 (USD Million)

Chapter 6. Neurovascular Devices Market: Segment Analysis, By End Use, 2021 - 2033 (USD Million)

• 6.1. Definition and Scope
• 6.2. Segment Dashboard
• 6.3. End Use Market Share Analysis, 2025 & 2033
• 6.4. Global Neurovascular Devices Market, by End Use, 2021 to 2033
• 6.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033
  • 6.5.1. Hospital
    • 6.5.1.1. Hospital market, 2021 - 2033 (USD Million)
  • 6.5.2. Specialty clinics
    • 6.5.2.1. Specialty clinics market, 2021 - 2033 (USD Million)
  • 6.5.3. Others
    • 6.5.3.1. Others market, 2021 - 2033 (USD Million)

Chapter 7. Neurovascular Devices Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Global Key company market share analysis, 2025
  • 8.3.4. Medtronic
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Stryker
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Terumo Corporation
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Penumbra, Inc.
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Johnson & Johnson and its affiliates
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. MicroPort Scientific Corporation
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Acandis GmbH
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. NeuroSafe Medical Co., Ltd.
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. Rapid Medical
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
  • 8.3.14. Evasc Neurovascular Enterprises
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives
  • 8.3.15. Lepu Medical Technology(Beijing) Co., Ltd.
    • 8.3.15.1. Company overview
    • 8.3.15.2. Financial performance
    • 8.3.15.3. Product benchmarking
    • 8.3.15.4. Strategic initiatives
  • 8.3.16. phenox GmbH (Wallaby Medical)
    • 8.3.16.1. Company overview
    • 8.3.16.2. Financial performance
    • 8.3.16.3. Product benchmarking
    • 8.3.16.4. Strategic initiatives
• 8.4. Heat Map Analysis/ Company Market Position Analysis
• 8.5. Estimated Company Market Share Analysis, 2025
• 8.6. List of Other Key Market Players-

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviation
• Table 3. North America neurovascular devices market, by country, 2021 - 2033 (USD Million)
• Table 4. North America neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 5. North America neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 6. North America neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 7. U.S. neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 8. U.S. neurovascular devices, by therapeutic application, 2021 - 2033 (USD Million)
• Table 9. U.S. neurovascular devices, by end use, 2021 - 2033 (USD Million)
• Table 10. Canada neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 11. Canada neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 12. Canada neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 13. Mexico neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 14. Mexico neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 15. Mexico neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 16. Europe neurovascular devices market, by country, 2021 - 2033 (USD Million)
• Table 17. Europe neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 18. Europe neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 19. Europe neurovascular devices market, by size, 2021 - 2033 (USD Million)
• Table 20. Europe neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 21. UK neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 22. UK neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 23. UK neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 24. Germany neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 25. Germany neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 26. Germany neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 27. France neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 28. France neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 29. France neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 30. Italy neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 31. Italy neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 32. Italy neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 33. Spain neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 34. Spain neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 35. Spain neurovascular devices market, by size, 2021 - 2033 (USD Million)
• Table 36. Spain neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 37. Norway neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 38. Norway neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 39. Norway neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 40. Sweden neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 41. Sweden neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 42. Sweden neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 43. Denmark neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 44. Denmark neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 45. Denmark neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 46. Asia Pacific neurovascular devices market, by country, 2021 - 2033 (USD Million)
• Table 47. Asia Pacific neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 48. Asia Pacific neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 49. Asia Pacific neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 50. China neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 51. China neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 52. China neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 53. Japan neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 54. Japan neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 55. Japan neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 56. India neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 57. India neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 58. India neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 59. Australia neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 60. Australia neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 61. Australia neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 62. South Korea neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 63. South Korea neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 64. Thailand neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 65. Thailand neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 66. Thailand neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 67. Thailand neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 68. Latin America neurovascular devices market, by country, 2021 - 2033 (USD Million)
• Table 69. Latin America neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 70. Latin America neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 71. Latin America neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 72. Brazil neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 73. Brazil neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 74. Brazil neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 75. Argentina neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 76. Argentina neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 77. Argentina neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 78. Middle East & Africa neurovascular devices market, by country, 2021 - 2033 (USD Million)
• Table 79. Middle East & Africa neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 80. Middle East & Africa neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 81. Middle East & Africa neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 82. South Africa neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 83. South Africa neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 84. South Africa neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 85. Saudi Arabia neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 86. Saudi Arabia neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 87. Saudi Arabia neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 88. UAE neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 89. UAE neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 90. UAE neurovascular devices market, by end use, 2021 - 2033 (USD Million)
• Table 91. Kuwait neurovascular devices market, by device, 2021 - 2033 (USD Million)
• Table 92. Kuwait neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
• Table 93. Kuwait neurovascular devices market, by end use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Neurovascular devices market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2025)
• Fig. 10 Segment Outlook
• Fig. 11 Strategy framework
• Fig. 12 Penetration & growth prospect mapping
• Fig. 13 Market driver relevance analysis (Current & future impact)
• Fig. 14 Market restraint relevance analysis (Current & future impact)
• Fig. 15 Porter's five forces analysis
• Fig. 16 SWOT analysis, by factor (political & legal, economic, and technological)
• Fig. 17 Neurovascular devices market: Device movement analysis
• Fig. 18 Neurovascular devices market device outlook: Key takeaways
• Fig. 19 Cerebral embolization and aneurysm coiling devices market, 2021 - 2033 (USD Million)
• Fig. 20 Embolic coils market, 2021 - 2033 (USD Million)
• Fig. 21 Flow diverters market, 2021 - 2033 (USD Million)
• Fig. 22 Liquid embolic agents market, 2021 - 2033 (USD Million)
• Fig. 23 Cerebral angioplasty and stenting systems market, 2021 - 2033 (USD Million)
• Fig. 24 Carotid artery stents market, 2021 - 2033 (USD Million)
• Fig. 25 Embolic protection systems devices market, 2021 - 2033 (USD Million)
• Fig. 26 Neurothrombectomy devices market, 2021 - 2033 (USD Million)
• Fig. 27 Clot retrieval devices market, 2021 - 2033 (USD Million)
• Fig. 28 Suction devices market, 2021 - 2033 (USD Million)
• Fig. 29 Vascular snares market, 2021 - 2033 (USD Million)
• Fig. 30 Support devices market, 2021 - 2033 (USD Million)
• Fig. 31 Micro catheters market, 2021 - 2033 (USD Million)
• Fig. 32 Guidewires market, 2021 - 2033 (USD Million)
• Fig. 33 Size market, 2021 - 2033 (USD Million)
• Fig. 34 0.027"market, 2021 - 2033 (USD Million)
• Fig. 35 0.021" market, 2021 - 2033 (USD Million)
• Fig. 36 0.021" market, 2021 - 2033 (USD Million)
• Fig. 37 0.071" market, 2021 - 2033 (USD Million)
• Fig. 38 0.046" market, 2021 - 2033 (USD Million)
• Fig. 39 0.019" market, 2021 - 2033 (USD Million)
• Fig. 40 0.013" market, 2021 - 2033 (USD Million)
• Fig. 41 0.058" market, 2021 - 2033 (USD Million)
• Fig. 42 0.068" market, 2021 - 2033 (USD Million)
• Fig. 43 Others market, 2021 - 2033 (USD Million)
• Fig. 44 Trans radial access devices market, 2021 - 2033 (USD Million)
• Fig. 45 Neurovascular devices market: Therapeutic application movement analysis
• Fig. 46 Neurovascular devices market therapeutic applications outlook: Key takeaways
• Fig. 47 Stroke market, 2021 - 2033 (USD Million)
• Fig. 48 Cerebral artery stenosis market, 2021 - 2033 (USD Million)
• Fig. 49 Cerebral aneurysm market, 2021 - 2033 (USD Million)
• Fig. 50 Aneurysmal subarachnoid hemorrhage market, 2021 - 2033 (USD Million)
• Fig. 51 Others market, 2021 - 2033 (USD Million)
• Fig. 52 Others market, 2021 - 2033 (USD Million)
• Fig. 53 Neurovascular devices market: End use movement analysis
• Fig. 54 Neurovascular devices market end use outlook: Key takeaways
• Fig. 55 Hospital market, 2021 - 2033 (USD Million)
• Fig. 56 Specialty clinics market, 2021 - 2033 (USD Million)
• Fig. 57 Others market, 2021 - 2033 (USD Million)
• Fig. 58 Regional outlook, 2025 & 2033
• Fig. 59 North America neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 60 U.S. neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 61 Canada neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 62 Mexico neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 63 Europe neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 64 UK neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 65 Germany neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 66 France neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 67 Italy neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 68 Spain neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 69 Norway neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 70 Denmark neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 71 Sweden neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 72 Asia Pacific neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 73 Japan neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 74 China neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 75 India neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 76 Australia neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 77 South Korea neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 78 Thailand neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 79 Latin America neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 80 Brazil neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 81 Argentina neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 82 MEA neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 83 South Africa neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 84 Saudi Arabia neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 85 UAE neurovascular devices market, 2021 - 2033 (USD Million)
• Fig. 86 Kuwait neurovascular devices market, 2021 - 2033 (USD Million)